LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Systemic lupus erythematosus and antineutrophil cytoplasmic antibody–associated vasculitis: An emerging overlap syndrome with cutaneous manifestations

Photo from wikipedia

AAV: antineutrophil cytoplasmic antibodyeassociated vasculitis ACR: American College of Rheumatology ANA: antinuclear antibody ANCA: antineutrophil cytoplasmic antibody anti-MPO: antimyeloperoxidase MCTD: mixed connective tissue disease p-ANCA: perinuclear antineutrophil cytoplasmic antibody RNP:… Click to show full abstract

AAV: antineutrophil cytoplasmic antibodyeassociated vasculitis ACR: American College of Rheumatology ANA: antinuclear antibody ANCA: antineutrophil cytoplasmic antibody anti-MPO: antimyeloperoxidase MCTD: mixed connective tissue disease p-ANCA: perinuclear antineutrophil cytoplasmic antibody RNP: ribonucleoprotein SLE/AAV: systemic lupus erythematosus antineutrophil cytoplasmic antibodyeassociated vasculitis overlap syndrome INTRODUCTION Systemic lupus erythematosus and antineutrophil cytoplasmic antibody (ANCA)eassociated vasculitis (SLE/AAV) overlap syndrome is a rare disease originally described in 2008. With only a few reports in the literature, this condition is characterized by aggressive crescentic glomerulonephritis, arthritis, cutaneous involvement, and both antinuclear antibody (ANA) and ANCA. Dermatologic manifestations are common and may occur at initial presentation. Although skin lesions may vary in morphology, the most commonly reported include cutaneous nodules and ecchymoses. Few reports have characterized the cutaneous findings seen in this disorder. We report a young woman with SLE/ AAV overlap syndrome who presented with a macular eruption and histopathology findings demonstrating interface dermatitis.

Keywords: vasculitis; systemic lupus; overlap syndrome; antibody; antineutrophil cytoplasmic; cytoplasmic antibody

Journal Title: JAAD Case Reports
Year Published: 2018

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.